Author Correction: SGLT2 inhibitors reduce the risk of renal failure in CKD stage 5 patients with Type 2 DM.

Saved in:
Bibliographic Details
Title: Author Correction: SGLT2 inhibitors reduce the risk of renal failure in CKD stage 5 patients with Type 2 DM.
Authors: Huang, Birdie1 (AUTHOR), Yen, Chieh-Li2,3 (AUTHOR), Wu, Chao-Yi3 (AUTHOR), Tsai, Chung-Ying2 (AUTHOR), Chen, Jia-Jin2,3 (AUTHOR), Hsiao, Ching-Chung2,3 (AUTHOR), Chen, Yung-Chang2,3 (AUTHOR), Hsieh, I-Chang1 (AUTHOR), Yang, Huang-Yu2,3,4 (AUTHOR) hyyang01@gmail.com
Source: Scientific Reports. 4/11/2025, Vol. 15 Issue 1, p1-1. 1p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-025-96996-3